Study of implanted scaffolds with follow-up in adults
Part of Heart & circulation clinical trials.
This study follows adults who have had at least one scaffold placed to see how they do over time. It also looks at whether people can stick with the required anti-platelet medicines for at least a year, and whether they can be followed for a year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years
- You must be willing to sign an informed consent form
- You must have had at least one scaffold implanted
- You must be able to come back or be reached for at least 1 year of follow-up
- You must be able to take dual anti-platelet medicines exactly as prescribed for at least 1 year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat long, narrow blockages in the heart's arteries. It combines a temporary scaffold with a drug-coated balloon, which may help the artery heal without a permanent metal stent. This could be an option for people who need their artery opened but may benefit from a less permanent approach.
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
This study is a follow-up registry that tracks how people do after doctors place a specific type of drug-eluting coronary stent. It may help doctors understand safety and outcomes of the Supraflex stent in real-world care.
This study compares two types of devices used to open blocked heart arteries during a heart attack or unstable chest pain: one is a scaffold made of magnesium that dissolves over time, the other is a permanent stent with a coating that releases medicine. The goal is to see which device works better for patients like you.
This study follows adults with blocked heart arteries who are treated using a special type of balloon (drug-coated balloon) during a procedure. It aims to track real-world outcomes to better understand how well this treatment works for people with new blockages or previously treated vessel narrowing.
This study looks at the long-term (10-year) outcomes of a specific stenting technique for patients with a chronic total occlusion (a complete blockage that has been there for at least 3 months) in a major heart artery. It aims to see how well the procedure works over time.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.